← brief for 2026-08-13 · Slowing decline

Effectiveness and Safety of Combined Semaglutide and Dapagliflozin Therapy in Type 2 Diabetes: A Retrospective Cohort Study.

Article B Peer reviewed Small trial

Key takeaways

A study of semaglutide and dapagliflozin combination therapy in patients with type 2 diabetes. It found no difference in cardiovascular or renal outcomes.

Who did this work

Alzahrani M · Alsudairy N · Al Asmari Z · Basubrain L · Saad H · Abdullatif A · Alawashiz Z · Alsulami N · Alrezqi M

Source

Article · PubMed, the drug frontier · 2026 Jul 12
https://pubmed.ncbi.nlm.nih.gov/42583162/